Afatinib after progression on osimertinib

Dear Doctors and Moderators,

  I have been on tarceva for 9 months and after progression and high toxicity moved to Tagrisso. Blood biopsy showed same l858r mutation, but no t790m one. My question is: if I progressed on osimertinib but keeping same original mutation, can I try afatinib?  Or Tagrisso plus afatinib combo? Or Tagrisso plus avastin? Retry tarceva plus Tagrisso combo?

Thank you very much for your assistance.

❤️

 

Tecentriq + Alimta Side Effects??

Hello! My mom got her first dose of Tecentriq & Alimta 3 weeks ago. She seems to have developed massive swelling in the right foot that’s moving up her leg (no clots per ultrasound).  She also has a burning sensation in her mouth.  Her next Alimta + Tecentriq infusion is on 7/4.  Would love some thoughts on what might be going on. Thank you so much!

Guardant 360 results

Hi, I hope someone from this great community can help. My mom was diagnosed with Stage 4 NSCLC 3.5 years ago. At the time of diagnosis she tested positive for EGFR l858r and was subsequently put on Tarceva which lasted a little over a year before she progressed. Went on Tagrisso for about 1.5 years. She recently tried carbo/alimpta/Keytruda but discontinued in March this year since she was still progressing after 3 rounds.

To stop Tarceva due to ground ground glass opacity , short of breath and cough

My GGO was not resolved after been on antibiotic and 30 mg of prednisone for a week. I have cough and shortness of breath. My pulmonologist thinks about 3 reasons: tarceva toxicity, cancer related lymphangitis ( cancer cells blocking lymph vessels) or fungal bacretial infection.  Bronchoscopy cant be done because my condition with lack of oxygen. So the plan is to stop tarceva for 1-2 weeks and keep 40 mg of prednisone to see how it will affect my breathing . I really worry about this break.

Progressed with Tarceva after 9 months. New mutations: l858r and MET H1112R please help with the choice of treatment.

Dear Doctors, could you please help me with the right treatment for newly detected mutation by blood biopsy. This is MET , exon 16, H1112R mutation in combination with my existing one which is exon 21, l858r. It has been reported that those two mutations exist in equal amounts. 

Subscribe to Stage IV NSCLC